Drug companies are using intellectual-property laws to price-gouge the public, and even Republicans don’t like it.
Revolving Door Project
Posted inMoney, Politics, and Power
Biden Must Block Crypto’s Access to the Revolving Door
Government officials should not be able to cash out working for firms directly affected by their own actions in office.
Posted inMoney, Politics, and Power
The Corporate Past of Jeffrey Zients
The administration’s highest-ranking COVID official built his wealth through billing practices that have been alleged as fraud, triggering hundreds of millions in fines.
Posted inPodcasts
The Hapless Merrick Garland
Why is Biden’s attorney general reluctant to charge Donald Trump and his cronies? Jeff Hauser explains.
Posted inEnergy and the Environment
Where the Government’s Environmental Lawyers Stand
The Environment and Natural Resources Division of the Justice Department could help protect our planet’s future.
Posted inEconomic Policy
The SEC Must Avoid Legitimizing Carbon Offsets
These are nothing more than financial trickery that lets polluters shirk responsibility.
Posted inPolitics
To Unify the Country, Biden Must Name Corporate Villains
Stephen Schwarzman is a political villain out of a comic book. Biden should needle him mercilessly.
Posted inMoney, Politics, and Power
Bloomberg’s Military Investments Unknown as He Heads to Pentagon Position
The billionaire former mayor was tapped to chair the Defense Innovation Board, a go-between for the military and Silicon Valley.
Posted inHealth and Social Policy
Making the Next Coronavirus Vaccine Truly Public
The vaccine developed at the Walter Reed Army Institute should not be privatized for maximum profit.
Posted inLaw and Justice
Garland Has Yet to De-Trumpify His Office of Legal Counsel
The Department of Justice has failed to revise dubious decisions made to shield Trump from scrutiny.